8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
                                  ------------
                                    FORM 8-K
                                  ------------
                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                                 April 22, 2005

                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

               Utah                                 87-0500306

  (State or other jurisdiction of          (IRS Employer Identification

          incorporation)                              Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable








Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:


[  ] Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)


[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)


[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))


[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))



Item 8.01         Other Events

On April 22, 2005, USANA Health Sciences, Inc. issued a press release announcing
an increase in the authorized dollar amount for additional repurchases of the
Company's common stock from $4.1 million to $10 million. The release also
announced that share repurchases will be made from time-to-time, in the open
market, through block trades or otherwise, and will be funded with internally
generated cash. A copy of the press release is furnished herewith as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The company will also post this document on its corporate website,
www.usanahealthsciences.com, under the "investors" link.


Item 9.01         Financial Statements and Exhibits (furnished herewith)

                  (c)      Exhibits

Exhibit 99.1      Press release issued by USANA Health Sciences, Inc. dated
                  April 22, 2005


                                       2




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                             USANA HEALTH SCIENCES, INC.

                             By:  /s/ Gilbert A. Fuller
                                  ---------------------
                                  Gilbert A. Fuller, Chief Financial Officer

Date: April 25, 2005


                                       3

EX-99.1

                                                                    Exhibit 99.1

USANA Board Authorizes $10 Million Share Repurchase Plan

    SALT LAKE CITY--(BUSINESS WIRE)--April 22, 2005--USANA Health
Sciences, Inc. (Nasdaq:USNA) today announced that its board of
directors has increased the authorized dollar amount for additional
repurchases of its outstanding shares of common stock from $4.1
million to $10.0 million.
    The share repurchase will be made from time-to-time, in the open
market, through block trades or otherwise, and will be funded with
internally generated cash.
    Prior to this authorization, USANA had approximately $4.1 million
remaining in its share repurchase plan, which was announced in
November 2004. During 2004, the Company repurchased a total of 1.2
million shares for a total investment of $34.9 million or an average
of $29.02 per share.
    USANA had 19,162,528 common shares outstanding as of April 2,
2005.

    About USANA

    USANA develops and manufactures high quality nutritional and
personal care products that are sold directly to Associates and
Preferred Customers throughout the United States, Canada, Australia,
New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico,
the Netherlands, and the United Kingdom. More information on USANA can
be found at http://www.usanahealthsciences.com.

    Safe Harbor

    This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the
Securities Exchange Act. Actual results could differ materially from
those projected in these forward-looking statements, which involve a
number of risks and uncertainties, including reliance upon our network
of independent Associates, the governmental regulation of our
products, manufacturing and marketing risks, and uncertainties
associated with our planned international expansion. The contents of
this release should be considered in conjunction with the risk
factors, warnings, and cautionary statements that are contained in our
most recent filings with the Securities and Exchange Commission.

    CONTACT: USANA Health Sciences, Inc.
             Investor Relations Manager
             Riley Timmer, 801-954-7100
             investor.relations@us.usana.com